Fecal microbiota transplantation as a novel therapy for ulcerative colitis: A systematic review and meta-analysis

Medicine (United States)

Volumn 95, Issue 23, 2016, Pages

  Sun, Dali ^a,b   Li, Weiming ^a   Li, Shumin ^a   Cen, Yunyun ^a   Xu, Qingwen ^a   Li, Yijun ^a   Sun, Yanbo ^a   Qi, Yuxing ^a   Lin, Yueying ^a   Yang, Ting ^a   Xu, Pengyuan ^a   Lu, Qiping ^b  

^a KUNMING MEDICAL UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL CRAMP; ABDOMINAL DISCOMFORT; ABDOMINAL DISTENSION; ABDOMINAL PAIN; ABNORMAL FECES COMPOSITION; ABSCESS; ARTICLE; BLOATING; CHILL; CLINICAL EFFECTIVENESS; CNKI DATABASE; COCHRANE LIBRARY; COLITIS; DIARRHEA; EVIDENCE BASED PRACTICE; FECAL MICROBIOTA TRANSPLANTATION; FEVER; FLATULENCE; HUMAN; MEDLINE; META ANALYSIS; MUSCLE CRAMP; PATIENT SAFETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECTAL ABSCESS; RECTUM DISEASE; RECTUM HEMORRHAGE; SORE THROAT; SYSTEMATIC REVIEW; ULCERATIVE COLITIS; VOMITING; WANFANG DATABASE; WEB OF SCIENCE; COLITIS, ULCERATIVE; MICROFLORA; PROCEDURES; REMISSION;

COLITIS, ULCERATIVE; FECAL MICROBIOTA TRANSPLANTATION; HUMANS; MICROBIOTA; REMISSION INDUCTION;

EID: 84975515694     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000003765     Document Type: Article

References (60)

1. Burisch J, Munkholm P. Inflammatory bowel disease epidemiology. Curr Opin Gastroenterol. 2013;29:357-362.
2. Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142:46-54.
3. Kirsner JB. The historical basis of idiopathic inflammatory bowel diseases. Inflamm Bowel Dis. 1995;1:2-26.
4. Dasgupta S, Kasper DL. Relevance of commensal microbiota in the treatment and prevention of inflammatory bowel disease. Inflamm Bowel Dis. 2013;19:2478-2489.
5. Benjamin JL, Hedin CR, Koutsoumpas A, et al. Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn's disease. Gut. 2011;60:923-929.
6. Meijer BJ, Dieleman LA. Probiotics in the treatment of human inflammatory bowel diseases: update 2011. J Clin Gastroenterol. 2011;45:S139-S144.
7. van Nood E, Vrieze A, Nieuwdorp M, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med. 2013;368:407-415.
8. Bennet JD, Brinkman M. Treatment of ulcerative-colitis by implantation of normal colonic flora. Lancet. 1989;1:164.
9. Scaldaferri F, Pecere S, Bruno G, et al. An open-label, pilot study to assess feasibility and safety of fecal microbiota transplantation in patients with mild-moderate ulcerative colitis: preliminary results. Gastroenterology. 2015;148:S870.
10. Suskind DL, Singh N, Nielson H, et al. Fecal Microbial transplant via nasogastric tube for active pediatric ulcerative colitis. JPGN. 2015;60:27-29.
11. Wei Y, Zhu WM, Gong JF, et al. Fecal microbiota transplantation improves the quality of life in patients with inflammatory bowel discopic administration of fecal microbiota to patients with ulcera-tive colitis. Gastroenterol Res Pract. 2015;2015:1-5.
12. Cui B, Li P, Xu L, et al. Step-up fecal microbiota transplantation strategy: a pilot study for steroid-dependent ulcerative colitis. J Transl Med. 2015;13:298-340.
13. Ren RR, Sun G, Yang YS, et al. A pilot study of treating ulcerative colitis with fecal microbiota transplantation. Zhong Hua Nei Ke Za Zhi (Chinese). 2015;54:411-415.
14. Moayyedi P, Surette MG, Kim PT, et al. Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial. Gastroenterology. 2015;149:102-109.
15. Rossen NG, Fuentes S, van der Spek MJ, et al. Findings from a randomized controlled trial of fecal transplantation for patients with ulcerative colitis. Gastroenterology. 2015;149:110-118.
16. Colman RJ, Rubin DT. Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis. J Crohns Colitis. 2014;8:1569-1581.
17. Anderson JL, Edney RJ, Whelan K. Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease. Aliment Pharmacol Ther. 2012;36:503-516.
18. Ianiro G, Bibbo S, Scaldaferri F, et al. Fecal microbiota transplantation in inflammatory bowel disease: beyond the excitement. Medicine. 2014;93:e97.
19. Sha S, Liang J, Chen M, et al. Systematic review: faecal microbiota transplantation therapy for digestive and nondigestive disorders in adults and children. Aliment Pharmacol Ther. 2014;39:1003-1032.
20. Wells G, Shea B, O'connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2000; http://www.evidencebasedpublichealth.de/download/Newcastle-Ottowa-Scale-Pope-Bruce.pdf (Accessed September 2015).
21. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.
22. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008-2012.
23. Kump PK, Grochenig HP, Lackner S, et al. Alteration of intestinal dysbiosis by fecal microbiota transplantation does not induce remission in patients with chronic active ulcerative colitis. Inflamm Bowel Dis. 2013;19:2155-2165.
24. Kunde S, Pham A, Bonczyk S, et al. Safety, tolerability, and clinical response after fecal transplantation in children and young adults with ulcerative colitis. J Pediatr Gastroenterol Nutr. 2013;56:597-601.
25. Kassam Z, Lee CH, Yuan Y, et al. Fecal microbiota transplantation for clostridium difficile Infection: systematic review and meta-analysis. Am J Gastroenterol. 2013;108:500-508.
26. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions version 5.1.0 [updated March 2011]. The cochrane collaboration; 2011. Accessed at www.cochrane-handboo-k.org on October 1, 2015.
27. Nannini C, West CP, Erwin PJ, et al. Effects of cyclophosphamide on pulmonary function in patients with scleroderma and interstitial lung disease: a systematic review and meta-analysis of randomized controlled trials and observational prospective cohort studies. Arthritis Res Ther. 2008;10:R124.
28. Wallace BC, Schmid CH, Lau J, et al. Meta-Analyst: software for meta-analysis of binary, continuous and diagnostic data. BMC Med Res Methodol. 2009;9:80.
29. Deeks J, Higgins J, Altman D, on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group. Chapter 9: Analysing data and undertaking meta-analyses. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]: The Cochrane Collaboration. 2008.
30. Aas J, Gessert CE, Bakken JS. Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube. Clin Infec Dis. 2003;36: 580-585.
31. Borody TJ, Wettstein AR, Leis S, et al. Clostridium difficile complicating inflammatory bowel disease: pre-and post-treatment findings. Gastroenterology. 2008;134:A361.
32. Wettstein A, Borody TJ, Leis SM, et al. Fecal bacteriotherapy-an effective treatment for relapsing symptomatic clostridium difficile infection. In: 15th United European Gastroenterology Week 2007; France 2007.
33. Zainah H, Silverman A. Fecal bacteriotherapy: a case report in an immunosuppressed patient with ulcerative colitis and recurrent Clos-tridium difficile infection. Case Rep Infect Dis. 2012;2012:810-943.
34. Watson JB, Habr F, Kelly C. First reported complication of fecal microbiota transplant: ulcerative colitis flare after FMT for relapsing Clostridium difficile infection. Gastroenterology. 2012;142:S540.
35. Annalisa A, Giovanni C, Claudio P, et al. Fecal microbiota transplantation for recurrent C. difficile infection in a patient with chronic refractory ulcerative colitis. J Crohns Colitis. 2015;9:367.
36. Hourigan SK, Chen LA, Grigoryan Z, et al. Microbiome changes associated with sustained eradication of Clostridium difficile after single faecal microbiota transplantation in children with and without inflammatory bowel disease. Aliment Pharmacol Ther. 2015;42:741-752.
37. Espinoza R, Quera R, Meyer L, et al. Fecal microbiota transplantation: first case report in Chile and review. Rev Chil Infectol. 2014;31:477-482.
38. Brace C, Gloor GB, Mark R, et al. Microbial composition analysis of Clostridium difficile infections in an ulcerative colitis patient treated with multiple fecal microbiota transplantations. J Crohns Colitis. 2014;8:1133-1137.
39. DeLeon LM, Watson JB, Kelly CR, et al. Transient flare of ulcerative colitis after fecal microbiota transplantation for recurrent clostridium difficile infection. Clin Gastroenterol Hepatol. 2013;11:1036-1038.
40. Ma CE, Peng NH, Sun QL, et al. Nursing care of fecal microbiota transplantation in one case of ulcerative colitis. J Nurs Sci (Chinese). 2014;29:41-42.
41. Borody TJ, George L, Andrews P, et al. Bowel-flora alteration- A potential cure for inflammatory bowel-disease and irritable bowel syndrome. Med J Australia. 1989;150:604.
42. Borody TJ, Leis S, McGrath K, et al. Treatment of chronic constipation and colitis using human probiotic infusions. In: Probiotics, Prebiotics and New Foods Conference; Universita Urbaniana, Rome; September 2-4, 2001.
43. Borody TJ, Warren EF, Leis S, et al. Treatment of ulcerative colitis using fecal bacteriotherapy. J Clin Gastroenterol. 2003;37: 42-47.
44. Vandenplas Y, Veereman G, van dWTBJ, et al. Fecal microbial transplantation in a one-year-old girl with early onset colitis-caution advised. J Pediatr Gastroenterol Nutr. 2015;61:e12-e14.
45. Borody T, Campbell J, Torres M, et al. Reversal of idiopathic thrombocytopenic purpura [ITP] with fecal microbiota transplantation [FMT]. Am J Gastroenterol. 2011;106:S352.
46. Borody TJ, Torres M, Campbell J, et al. Reversal of inflammatory bowel disease (IBD) with recurrent faecal microbiota transplants (FMT). Am J Gastroenterol. 2011;106:S366.
47. Ni XD, Li YX, Zhang YL, et al. Enteral nutrition fecal microbiota transplantation via percutaneous endoscopic cecostomy in treatment of recurrent ulcerative colitis. CPEN (Chinese). 2015;22: 29-33.
48. Landy J, Walker AW, Li J, et al. Variable alterations of the microbiota, without metabolic or immunological change, following faecalmicrobiota transplantation in patients with chronic pouchitis. Sci Rep. 2015;5:12955.
49. Chunmei Li. Observation and nursing of refractory IBD patients with fecal bacteria transplantation. Basic Med Forum (Chinese). 2015;19:2285-2286.
50. Ishikawa D, Osada T, Sasaki T, et al. Alterations of intestinal microbiota in ulcerative colitis patients treated with sequential antibiotic combination and faecal microbiota transplantation. J Crohns Colitis. 2015;9(Suppl 1):S364-S365.
51. Wang M, Wang H, Zhang F. Standard fecal microbiota transplantation through mid-gut is effective therapy for refractory ulcerative colitis. J Gastroenterol Hepatol. 2013;28(Suppl.3):590.
52. Angelberger S, Reinisch W, Makristathis A, et al. Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation. Am J Gastroenterol. 2013;108:1620-1630.
53. Damman CJ, Brittnacher MJ, Westerhoff M, et al. Low level engraftment and improvement following a single colonoscopic administration of fecal microbiota to patients with ulcerative colitis. PLoS One. 2015;10:e0133925.
54. Drekonja D, Reich J, Gezahegn S, et al. Fecal microbiota transplantation for Clostridium difficile Infection: a systematic review. Ann Intern Med. 2015;162:630-638.
55. Britton RA, Young VB. Role of the intestinal microbiota in resistance to colonization by Clostridium difficile. Gastroenterology. 2014;146:1547-1553.
56. Fedorak RN. Probiotics in the management of ulcerative colitis. Gastroenterol Hepatol (N Y). 2010;6:688-690.
57. Rembacken BJ, Snelling AM, Hawkey PM, et al. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet. 1999;354:635-639.
58. Mardini HE, Grigorian AY. Probiotic mix VSL#3 is effective adjunctive therapy for mild to moderately active ulcerative colitis: a meta-analysis. Inflamm Bowel Dis. 2014;20:1562-1567.
59. Youngster I, Sauk J, Pindar C, et al. Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study. Clin Infect Dis. 2014;58:1515-1522.
60. Cammarota G, Ianiro G, Gasbarrini A. Fecal microbiota transplantation for the treatment of Clostridium difficile infection. A systematic review. J Clin Gastroenterol. 2014;48:693-702.